Learn More
Apexbio Technology LLC AT13148 1056901-62-2 50mg

Supplier: Apexbio Technology LLC B415850
AT13148 (CAS 1056901-62-2) is an orally bioavailable ATP-competitive inhibitor targeting multiple AGC family kinases including AKT (IC50 38 nM) p70S6 kinase (IC50 8 nM) PKA (IC50 3 nM) SGK (IC50 63 nM) and Rho kinase (IC50 4 nM) In vitro AT13148 suppresses AGC kinase activity and inhibits proliferation in various human cancer cell lines with GI50 values ranging from 1 54 M to 3 77 M In vivo studies demonstrate its antitumor efficacy in human xenograft models such as PTEN-deficient MES-SA uterine sarcoma and HER2-positive PIK3CA-mutant BT474 breast cancer This molecule is valuable for investigating AGC kinase signaling and tumor biology
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.